Holger Amthauer

Papers

Total Citations

H-Index

About

Holger Amthauer is a leading figure in molecular imaging and hybrid diagnostics, with a primary focus on neuro-oncology and targeted radionuclide therapy. His research centers on the clinical translation of PET/CT and PET/MRI, particularly using somatostatin receptor analogs like ⁶⁸Ga-DOTATOC to improve tumor characterization and treatment planning. A landmark contribution is his pioneering work on ⁶⁸Ga-DOTATOC-PET/MRI as a "one-stop shop" imaging tool for robotic radiosurgery in patients with optic nerve sheath meningioma (ONSM), a rare condition that can cause irreversible blindness. His 2021 study demonstrated that receptor-based hybrid imaging enhances tumor delineation and diagnostic accuracy, offering a secure, non-invasive approach to guide precise radiotherapy. This work has garnered 13 citations and is recognized for addressing a critical clinical gap. Amthauer’s impact extends beyond ONSM; his broader portfolio includes advancing theranostics—combining diagnostic imaging with targeted therapy—to personalize cancer care. With a career marked by high-impact publications and interdisciplinary collaboration, he continues to shape how hybrid imaging informs surgical and radiosurgical decisions, ultimately improving patient outcomes in neuro-oncology.